Further, IL-11 alone stimulates the recovery of platelets after radiation therapy, in mice [13], and its recombinant version has been approved by the FDA to treat radiation-induced thrombocytopenia in tumour patients (e.g., breast cancer) [14]. The gene discussed is IL11; the disease is breast carcinoma.